![Rui Zhou](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rui Zhou
Direktor/Vorstandsmitglied bei
MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.
Profil
Rui Zhou is currently an Independent Non-Executive Director at Mabwell (Shanghai) Bioscience Co., Ltd. since 2026 and an Independent Director at Yantai Dongcheng Biochemicals Co., Ltd. since 2025.
Former positions include Director of Pharmaceutical Industry Investment at China Universal Asset Management Co., Ltd., Independent Director at Humanwell Healthcare (Group) Co., Ltd. from 2021 to 2025, and Research Analyst at Haitong Securities Co., Ltd. (Broker).
Aktive Positionen von Rui Zhou
| Unternehmen | Position | Beginn |
|---|---|---|
| MABWELL (SHANGHAI) BIOSCIENCE CO., LTD. | Direktor/Vorstandsmitglied | 18.06.2026 |
| YANTAI DONGCHENG PHARMACEUTICAL GROUP CO.,LTD. | Direktor/Vorstandsmitglied | 15.09.2025 |
Ehemalige bekannte Positionen von Rui Zhou
| Unternehmen | Position | Ende |
|---|---|---|
| HUMANWELL HEALTHCARE (GROUP) CO.,LTD. | Direktor/Vorstandsmitglied | 30.07.2025 |
Haitong Securities Co., Ltd. (Broker)
 Haitong Securities Co., Ltd. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
China Universal Asset Management Co., Ltd.
 China Universal Asset Management Co., Ltd. Investment ManagersFinance CUAM is an active manager which aims to generate alpha over the medium- to long-term in a fast growing emerging market like China. They adopt a holistic approach to investing and employ in-depth, bottom-up fundamental research to identify winning stocks. They offers various China equity, fixed income and money market strategies through a wide range of investment vehicles including equity funds, index funds, hybrid funds, guaranteed funds, bond funds, money market funds and QDII (Qualified Domestic Institutional Investor) funds. | Head-Equity Investments | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
45
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Humanwell Healthcare (Group) Co., Ltd.
 Humanwell Healthcare (Group) Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes biochemical products and medicines; manufactures electronic computers | Health Technology |
China Universal Asset Management Co., Ltd.
China Universal Asset Management Co., Ltd. Investment ManagersFinance CUAM is an active manager which aims to generate alpha over the medium- to long-term in a fast growing emerging market like China. They adopt a holistic approach to investing and employ in-depth, bottom-up fundamental research to identify winning stocks. They offers various China equity, fixed income and money market strategies through a wide range of investment vehicles including equity funds, index funds, hybrid funds, guaranteed funds, bond funds, money market funds and QDII (Qualified Domestic Institutional Investor) funds. | Finance |
Haitong Securities Co., Ltd. (Broker)
Haitong Securities Co., Ltd. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Yantai Dongcheng Biochemicals Co., Ltd.
 Yantai Dongcheng Biochemicals Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacture, & sale of heparin active pharmaceutical ingredient and chondroitin sulfate | Health Technology |
Mabwell (Shanghai) Bioscience Co., Ltd.
 Mabwell (Shanghai) Bioscience Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceuticals for oncology & age related ophthalmology, orthopedics and immunology diseases | Health Technology |
